The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The FDA approved a new treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 12 years of age and older with hemophilia A or B, both without inhibitors.

U.S. District Court for the Eastern District of California entered a consent decree of permanent injunction against Rizo Lopez Foods Inc. prohibiting the company from manufacturing and selling certain food products until the company complies with the FD&C Act and other federal regulations.

FDA granted marketing authorization for the Healgen Rapid Check COVID-19/Flu A&B Antigen Test

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.